搜索临床试验以:恩杂鲁胺(Xtandi)
总计502个结果
-
The European Uro-Oncology GroupCentre for Human Drug Research, Netherlands完全的
-
Nuvation Bio Inc.招聘中乳腺癌 | 胰腺癌 | 卵巢癌 | 前列腺癌 | 乳腺癌 | 三阴性乳腺癌 | 三阴性乳腺肿瘤 | 晚期实体瘤 | 卵巢癌 | 胰腺癌 | 三阴性乳腺癌 | 胰腺癌 | 胰腺肿瘤 | 前列腺肿瘤 | 前列腺癌 | 前列腺癌 | 卵巢癌 | 乳腺癌 | 胰腺癌 | 乳腺肿瘤 | 去势抵抗性前列腺癌 | 乳腺癌 | 前列腺癌 | 去势抵抗性前列腺癌 | 卵巢肿瘤 | 卵巢癌 | 去势抵抗性前列腺肿瘤美国, 澳大利亚
-
Wake Forest University Health SciencesAstellas Pharma Inc; Medivation, Inc.主动,不招人
-
Oslo University HospitalDiakonhjemmet Hospital; Sykehuset Telemark; Helse Forde; Sykehuset Ostfold; Sykehuset i Vestfold HF; Sykehuset Asker og Baerum完全的
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的
-
Julie Graff, MDJohns Hopkins University; Merck Sharp & Dohme LLC; Oregon Health and Science University; Prostate...招聘中
-
Dana-Farber Cancer InstitutePfizer; Astellas Pharma Inc完全的
-
PfizerAstellas Pharma Inc; Medivation, Inc.主动,不招人
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 复发性乳腺癌 | HER2/Neu 阴性 | 三阴性乳腺癌 | 晚期乳腺癌 | 雄激素受体阳性 | 转移性乳腺癌 | PTEN阳性 | 难治性乳腺癌美国
-
University of Texas Southwestern Medical CenterAstellas Pharma US, Inc.完全的
-
University of PennsylvaniaNational Institute on Minority Health and Health Disparities (NIMHD)完全的
-
OHSU Knight Cancer InstituteMerck Sharp & Dohme LLC; Oregon Health and Science University; Collins Medical Trust主动,不招人去势抵抗性前列腺癌 | 复发性前列腺癌 | PSA 进展 | 激素抵抗性前列腺癌 | IV 期前列腺癌 AJCC v8美国
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKline; Novartis; Astellas Pharma Inc; Prostate Cancer Foundation; Medivation, Inc.主动,不招人
-
Groupe Hospitalier Pitie-Salpetriere完全的
-
Roswell Park Cancer Institute撤销去势抵抗性前列腺癌 | IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | PSA 进展 | 软组织转移性前列腺癌 | 睾酮的去势水平 | 前列腺癌骨转移 | PSA 水平大于或等于 2美国
-
University of California, San FranciscoNational Comprehensive Cancer Network终止
-
Astellas Pharma Inc完全的
-
Astellas Pharma China, Inc.主动,不招人
-
PfizerAstellas Pharma Inc; Medivation, Inc.撤销
-
Andreas JosefssonGöteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall Hospital; Skane University Hospital 和其他合作者终止
-
Translational Research Center for Medical Innovation...Kagawa University完全的
-
H. Lee Moffitt Cancer Center and Research InstituteAstellas Pharma Inc完全的
-
RTOG Foundation, Inc.Pfizer; Astellas Pharma Inc主动,不招人
-
Gustave Roussy, Cancer Campus, Grand Paris主动,不招人
-
Grupo Español de Tumores Huérfanos e InfrecuentesAstellas Pharma Inc; Apices Soluciones S.L.完全的
-
Hinova Pharmaceuticals USA, Inc.主动,不招人去势抵抗性前列腺癌 | 前列腺癌转移德国, 西班牙, 丹麦, 法国, 英国, 俄罗斯联邦, 波兰, 澳大利亚, 意大利, 荷兰, 美国, 芬兰, 加拿大, 奥地利
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation完全的
-
The European Uro-Oncology GroupCentre for Human Drug Research, Netherlands完全的
-
European Organisation for Research and Treatment...Bayer; Latin American Cooperative Oncology Group; UNICANCER; Astellas Pharma Europe Ltd.; Cancer Trials... 和其他合作者主动,不招人
-
Astellas Pharma Global Development, Inc.Medivation, Inc.撤销
-
University of Southern CaliforniaNational Cancer Institute (NCI)主动,不招人